loading...| Preferred Name |
Aminolevulinic Acid |
|
| Synonyms |
|
|
| Definitions |
A topically administered metabolic precursor of protoporphyrin IX. After topical administration, aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX) which is a photosensitizer. When the proper wavelength of light activates protoporphyrin IX, singlet oxygen is produced, resulting in a local cytotoxic effect. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C234 |
|
| ALT_DEFINITION |
The active ingredient in a drug used to treat actinic keratosis (a skin condition that may become cancer). The drug is also being studied in the treatment of squamous cell and basal cell skin cancers and other types of cancer. When aminolevulinic acid is taken up by cells, including cancer cells, and then exposed to certain types of light, it becomes active and kills the cells. It is a type of photosensitizing agent. |
|
| CAS_Registry |
106-60-5 |
|
| CHEBI_ID |
CHEBI:17549 |
|
| Chemical_Formula |
C5H9NO3 |
|
| code |
C234 |
|
| Contributing_Source |
FDA |
|
| definition |
A topically administered metabolic precursor of protoporphyrin IX. After topical administration, aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX) which is a photosensitizer. When the proper wavelength of light activates protoporphyrin IX, singlet oxygen is produced, resulting in a local cytotoxic effect. (NCI04) |
|
| FDA_UNII_Code |
88755TAZ87 |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Aminolevulinic Acid |
|
| Legacy Concept Name |
Aminolevulinic_Acid |
|
| NCI_Drug_Dictionary_ID |
791850 |
|
| PDQ_Closed_Trial_Search_ID |
791850 |
|
| PDQ_Open_Trial_Search_ID |
791850 |
|
| Preferred_Name |
Aminolevulinic Acid |
|
| prefixIRI |
NCIT:C234 |
|
| prefLabel |
Aminolevulinic Acid |
|
| Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance |
|
| UMLS_CUI |
C0002563 |
|
| subClassOf |